Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma.

Jagannath S, Vesole DH, Zhang M, Desikan KR, Copeland N, Jagannath M, Bracy D, Jones R, Crowley J, Tricot G, Barlogie B.

Bone Marrow Transplant. 1997 Sep;20(6):445-50.

2.

The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.

Peters WP, Ross M, Vredenburgh JJ, Hussein A, Rubin P, Dukelow K, Cavanaugh C, Beauvais R, Kasprzak S.

Semin Oncol. 1994 Aug;21(4 Suppl 7):25-31.

PMID:
7916487
3.

Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma.

Morabito F, Martino M, Stelitano C, Oliva E, Kropp M, Irrera G, Console G, Fujo M, Messina G, Molica S, Callea V, Iacopino P.

Haematologica. 2002 Nov;87(11):1192-9.

5.

High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.

Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.

Natl Med J India. 2003 Jan-Feb;16(1):16-21.

PMID:
12715951
6.

Reduced charges and costs associated with outpatient autologous stem cell transplantation.

Meisenberg BR, Ferran K, Hollenbach K, Brehm T, Jollon J, Piro LD.

Bone Marrow Transplant. 1998 May;21(9):927-32.

7.

Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years.

Corso A, Mangiacavalli S, Barbarano L, Alessandrino EP, Cairoli R, Morra E, Lazzarino M; HOST Group.

Cancer. 2007 Jun 1;109(11):2273-8.

8.

Transplantation as salvage therapy for high-risk patients with myeloma in relapse.

Lee CK, Barlogie B, Zangari M, Fassas A, Anaissie E, Morris C, Van Rhee F, Cottler-Fox M, Thertulien R, Muwalla F, Mazher S, Badros A, Tricot G.

Bone Marrow Transplant. 2002 Dec;30(12):873-8.

9.
10.
11.

Total therapy with tandem transplants for newly diagnosed multiple myeloma.

Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S, Mehta J, Anaissie E, Dhodapkar D, Naucke S, Cromer J, Sawyer J, Epstein J, Spoon D, Ayers D, Cheson B, Crowley J.

Blood. 1999 Jan 1;93(1):55-65.

12.

Outpatient high-dose melphalan in multiple myeloma patients.

Kassar M, Medoff E, Seropian S, Cooper DL.

Transfusion. 2007 Jan;47(1):115-9.

PMID:
17207239
13.

[Intensive treatment of multiple myeloma].

Harousseau JL.

Bull Acad Natl Med. 2003;187(2):405-13; discussion 413-5. Review. French.

PMID:
14556449
14.

Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.

Holbro A, Ahmad I, Cohen S, Roy J, Lachance S, Chagnon M, LeBlanc R, Bernard L, Busque L, Roy DC, Sauvageau G, Kiss TL.

Biol Blood Marrow Transplant. 2013 Apr;19(4):547-51. doi: 10.1016/j.bbmt.2012.12.006. Epub 2012 Dec 16.

15.
16.

Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.

Vogl DT, Liu SV, Chong EA, Luger SM, Porter DL, Schuster SJ, Tsai DE, Perl A, Loren AW, Goldstein SC, Nasta SD, Andreadis C, Mangan PA, Hummel K, Siegel DL, Glatstein E, Stadtmauer EA.

Am J Hematol. 2007 Dec;82(12):1071-5.

17.

Autologous bone marrow harvesting in outpatients.

Thorne AC, Malbin KF, Jain M, Stewart M, Gulati SC.

J Clin Anesth. 1996 Nov;8(7):551-6.

PMID:
8910176
18.

Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiation.

Hunter HM, Peggs K, Powles R, Rahemtulla A, Mahendra P, Cavenagh J, Littlewood T, Potter M, Hunter A, Pagliuca A, Williams CD, Cook G, Towlson K, Marks David I, Russell NH; Clinical Trials Committee of the British Society of Blood and Marrow Transplantation (BSBMT).

Br J Haematol. 2005 Feb;128(4):496-502.

PMID:
15686458
19.

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.

Gertz MA, Lacy MQ, Inwards DJ, Chen MG, Pineda AA, Gastineau DA, Greipp PR, Lust JA, Tefferi A, Witzig TE, Kyle RA, Litzow MR.

Bone Marrow Transplant. 1999 Feb;23(3):221-6.

20.

Autologous blood and marrow transplantation in patients 60 years and older.

Leger CS, Bredeson C, Kearns B, Bence-Bruckler I, Atkins H, Huebsch L.

Biol Blood Marrow Transplant. 2000;6(2A):204-10.

PMID:
10816029

Supplemental Content

Support Center